Importation from Canada dropping
Executive Summary
According to Health Canada, there has been a substantial and steady decline in cross-border drug sales since the beginning of 2006 - a trend that could temper support for importation legislation, which will likely be considered in the Democrat-led Congress (1"The Pink Sheet" Nov. 13, 2006, p. 3). In light of possible action and a recent U.S. law allowing personal importation, groups representing Canadian pharmacists, patients and distributors recently requested an immediate ban on bulk and retail drug exports. Health Canada says such a ban would be "premature" and that it sees no evidence to suggest individual importation poses an imminent threat to the Canadian drug supply...
You may also be interested in...
Democratic Capitol Hill Will Create Challenges For Brand Industry
The sweep of both houses of Congress in the midterm elections will allow the Democrats the opportunity to push their agenda through must-pass legislation such as the reauthorization of the Prescription Drug User Fee Act
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.